Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for the health and nutrition sectors, announces the successful completion of its acquisition of IFF Pharma Solutions. This strategic milestone marks a significant step forward in its ambition to become a leader in support of the global pharma markets.

With this acquisition, and following that of Qualicaps in 2023, Roquette decisively strengthens its position as a key player in the health industry by integrating IFF Pharma Solutions’ expertise and innovative product portfolio.

The transaction enhances Roquette’s ability to deliver high-value drug delivery solutions to pharmaceutical customers worldwide while reinforcing its commitment to innovation. The acquisition aligns perfectly with Roquette’s long-term strategy of investing in high-growth markets across the globe and providing cutting-edge solutions that meet evolving industry needs.

Pierre Courduroux, CEO of Roquette, commented: “The successful acquisition of IFF Pharma Solutions marks a major step forward in our value-creation journey. We are thrilled to officially welcome our new colleagues as we start to write the next chapter of Roquette's history. This pivotal move aligns perfectly with our strategic vision to provide innovative, high-quality excipients that improve the efficacy and safety of pharmaceutical formulations. By combining our strengths, Roquette is poised to become the pharmaceutical industry’s go-to partner for the development of drug delivery solutions that contribute to improving, sustaining, and saving patients’ lives.”